PFKM and cancer: In particular, c-MYC and HIF-1α promote the expression of glycolytic enzymes hexokinase 2 (HK2), phosphofructokinase 1 (PFK1), triosephosphate isomerase 1 (TPI1), lactate dehydrogenase A (LDHA) in cancer (22).